 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 09/09/2019 |
$2.66 |
$2.72 |
$2.55 |
$2.58 |
56.70K | | 09/10/2019 |
$2.77 |
$2.77 |
$2.59 |
$2.63 |
66.90K | | 09/11/2019 |
$2.63 |
$2.80 |
$2.60 |
$2.77 |
121.60K | | 09/12/2019 |
$2.74 |
$2.74 |
$2.56 |
$2.64 |
63.90K | | 09/13/2019 |
$2.67 |
$2.67 |
$2.54 |
$2.56 |
34.00K |
|
|
| AgeX Therapeutics is a biotechnology company focused on the development and commercialization of novel therapeutics targeting human aging. Co.'s proprietary technology, based on telomerase-mediated cellular immortality and regenerative biology, allows Co. to utilize telomerase-expressing regenerative Pluripotent Stem Cells (“PSCs”) for the manufacture of cell-based therapies to regenerate tissues afflicted with age-related chronic degenerative disease. Co.'s products under development include two cell-based therapies derived from telomerase-positive PSCs and two product candidates derived from its proprietary induced Tissue Regeneration technology. | |
|
AgeX Therapeutics (AGE) has the following price history information. Looking back at AGE historical stock prices for the last five trading days, on September 09, 2019, AGE opened at $2.66, traded as high as $2.72 and as low as $2.55, and closed at $2.58. Trading volume was a total of 56.70K shares. On September 10, 2019, AGE opened at $2.77, traded as high as $2.77 and as low as $2.59, and closed at $2.63. Trading volume was a total of 66.90K shares. On September 11, 2019, AGE opened at $2.63, traded as high as $2.80 and as low as $2.60, and closed at $2.77. Trading volume was a total of 121.60K shares. On September 12, 2019, AGE opened at $2.74, traded as high as $2.74 and as low as $2.56, and closed at $2.64. Trading volume was a total of 63.90K shares. On September 13, 2019, AGE opened at $2.67, traded as high as $2.67 and as low as $2.54, and closed at $2.56. Trading volume was a total of 34.00K shares.
AGE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AgeX Therapeutics shares, starting with a $10,000 purchase of AGE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
11/29/2018 |
|
| End date: |
09/13/2019 |
|
| Start price/share: |
$2.71 |
|
| End price/share: |
$2.56 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-5.54% |
|
| Annualized Gain: |
-7.04% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$9,446.00 |
|
| Years: |
0.79 |
|
|
|
| Date |
Close |
| 09/09/2019 | $2.58 | | 09/10/2019 | $2.63 | | 09/11/2019 | $2.77 | | 09/12/2019 | $2.64 | | 09/13/2019 | $2.56 |
|
|
